Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species

被引:69
|
作者
Gerassimou, C.
Kotanidou, A.
Zhou, Z.
Simoes, D. C. M.
Roussos, C.
Papapetropoulos, A. [1 ]
机构
[1] Univ Athens, Dept Crit Care & Pulm Serv, George P Livanos Lab, Evangelismos Hosp, Athens 10675, Greece
[2] Univ Patras, Dept Pharm, Mol Pharmacol Lab, Patras, Greece
关键词
cGMP; soluble guanylyl cyclase; reactive oxygen species; nitric oxide;
D O I
10.1038/sj.bjp.0707179
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Superoxide anions produced during vascular disease scavenge nitric oxide ( NO), thereby reducing its biological activity. The aim of the present study was to investigate whether reactive oxygen species ( ROS) have a direct effect on soluble guanylyl cyclase ( sGC) subunit levels and function and to ascertain the mechanism( s) involved. Experimental approach: Rat aortic smooth muscle cells ( RASM) or freshly isolated vessels were exposed to reactive oxygen species ( ROS)-generating agents and sGC subunit expression was determined at the mRNA and/or protein level. cGMP accumulation was also determined in RASM exposed to ROS. Key results: Incubation of smooth muscle cells with H2O2, xanthine/xanthine oxidase ( X/XO) or menadione sodium bisulphite ( MSB) significantly decreased protein levels of alpha 1 and beta 1 subunits of sGC and reduced SNP-induced cGMP formation. Similarly, sGC expression was reduced in freshly isolated vessels exposed to ROS-generating agents. The ROS-triggered inhibition of alpha 1 and beta 1 levels was not blocked by proteasome inhibitors, suggesting that decreased sGC protein was not due to protein degradation through this pathway. Real time RT-PCR analysis demonstrated a 68% reduction in steady state mRNA levels for the alpha 1 subunit following exposure to H2O2. In addition, alpha 1 promoter-driven luciferase activity in RASM decreased by 60% after H2O2 treatment. Conclusion and implications: We conclude that oxidative stress triggers a decrease in sGC expression and activity that results from reduced sGC steady state mRNA levels. Altered sGC expression is expected to contribute to the changes in vascular tone and remodeling observed in diseases associated with ROS overproduction.
引用
收藏
页码:1084 / 1091
页数:8
相关论文
共 50 条
  • [1] Regulation of soluble guanylyl cyclase
    Koesling, D
    Russwurm, M
    Friebe, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R1 - R1
  • [2] Posttranscriptional regulation of soluble guanylyl cyclase expression in rat aorta
    Klöss, S
    Mülsch, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R57 - R57
  • [3] Human recombinant soluble guanylyl cyclase: Expression, purification, and regulation
    Lee, YC
    Martin, E
    Murad, F
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (20) : 10763 - 10768
  • [4] Redox regulation of soluble guanylyl cyclase
    Muelsch, A
    Selemo, E
    Fichtlscherer, B
    Hoenicka, M
    CIRCULATION, 1999, 100 (18) : 264 - 264
  • [5] Redox regulation of soluble guanylyl cyclase
    Shah, Rohan C.
    Sanker, Subramaniam
    Wood, Katherine C.
    Durgin, Brittany G.
    Straub, Adam C.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2018, 76 : 97 - 104
  • [7] Regulation of soluble guanylyl cyclase by protoporphyrin agonists
    Nedvetsky, PI
    Nedvetskaya, TY
    Schmidt, P
    Taye, A
    Müller, H
    Stasch, JF
    Schmidt, HHHW
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R39 - R39
  • [8] Molecular aspects of soluble guanylyl cyclase regulation
    Andreopoulos, S
    Papapetropoulos, A
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 2000, 34 (03): : 147 - 157
  • [9] Studying the structure and regulation of soluble guanylyl cyclase
    Koesling, D
    METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1999, 19 (04): : 485 - 493
  • [10] Regulation of nitric oxide and soluble guanylyl cyclase
    Krumenacker, J
    Hanafy, KA
    Murad, F
    BRAIN RESEARCH BULLETIN, 2004, 62 (06) : 505 - 515